LEXX Message Board Post 9638588 | Lexaria Bioscience Corp.
home / stock / lexx / lexx message board
vasvani
(investorshub)
Posted on: Apr/29/2023 20:01:00
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171802808
Codfather, consider VOTING NO against repricing options as
News, Short Squeeze, Breakout and More Instantly...
-
Lexaria Bioscience Corp. (NASDAQ: LEXX) , a global innovator in drug delivery platforms, is doubling down on glucagon-like peptide 1 (“GLP-1”) studies for the 2024 calendar year. “The company is optimistic that the studies will yield positive results, not just in the potentia...
-
Lexaria, a global innovator in drug delivery platforms, has announced the successful completion of its second round of dosing for its human pilot study #2 The final study arm is set for completion in early July, and if successful, it will help remedy the downsides of swallowed administration ...
-
Lexaria Bioscience (NASDAQ: LEXX, LEXXW) , a global innovator in drug delivery platforms, today announced it has hired a contract research organization (“CRO”) to oversee execution of the company’s 12-week chronic study GLP-1-H24-4. The study will evaluate various DehydraTECH...